Biotech News
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
investors.mannkindcorp.com2026-05-06 14:54 EST
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), today announced Chief Executive Officer Michael Castagna, PharmD is scheduled to present and share business updates during the Oppenheimer 36 th Annual Healthcare Life Sciences